RECIST was developed in 2000 by the National Cancer Institute, European Organization for Research and Treatment of Cancer, and National Cancer Institute of Canada, with revision to RECIST 1.1 in 2009 ...
Integrated analyses of the Phase 2 PAISLEY-SLE and PAISLEY LTE studies showed that Sotyktu maintained a consistent safety profile and durable efficacy in patients with moderate-to-severe SLE with up ...
Constative on MSN
22 Nobel Prize Winners Who Changed the Way We Live
Every time a doctor orders a CT scan, or a child receives a lifesaving vaccine, or your phone’s GPS corrects itself by the ...
Obexelimab almost completely prevented new inflammatory lesions visible on brain scans of adults with relapsing MS, per trial data.
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
A study using wearable scanning technology has revealed how brain function differs in people with multiple sclerosis (MS). It ...
CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...
It may not hit for infinite damage, but this new necromancer build in Diablo 4 has infinite bullets, and that's close enough. The whole build involves pressing a single button to fire off bone ...
Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...
Speaking with democracy activists recently from Hungary and Poland, former President Barack Obama warned about the “rising wave of authoritarianism sweeping the globe,” even in countries once believed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results